Liminatus Pharma shares are trading lower. The company announced it amended its proposed $320 merger deal with InnocsAI.
Liminatus Pharma shares are trading lower. The company announced it amended its proposed $320 merger deal with InnocsAI.
Liminatus Pharma shares are trading lower.
The company announced it amended its proposed $320 merger deal with InnocsAI.